U.K. researchers found that 46% of Alzheimer's patients who were treated with psychiatric drugs, including Risperdal and Thorazine, were alive after two years, compared with 71% of those who took placebo. The study was conducted from 2001 to 2004 among 165 patients ages 67 to 100 with moderate to severe forms of the disease. The findings underscore the need for personalized drug therapies, an Alzheimer's specialist said.

Full Story:

Related Summaries